MHRA Class 2 Medicines Recall: Diazepam RecTubes 2.5mg Rectal Solution (Wockhardt UK Ltd)
MHRA Class 2 Medicines Recall: Diazepam RecTubes 2.5mg Rectal Solution (Wockhardt UK Ltd)
March 7, 2022
Class 2 Medicines recall: Diazepam RecTubes 2.5mg Rectal Solution (Wockhardt UK Ltd)
Drug alert number: EL (22) A/11
Date issued: 7th March 2022
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Diazepam RecTubes 2.5mg Rectal Solution (Wockhardt UK Ltd) PL 29831/0067
Wockhardt UK Ltd are recalling a batch of Diazepam RecTubes 2.5mg Rectal Solution due to an out of specification result for assay during routine stability testing.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| I55061 | January 2023 | 5 x 1.25ml | 27 April 2020 |
Active Pharmaceutical Ingredient: Diazepam
Advice for healthcare professionals
Stop supplying the above batch immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Company contacts for further information
For more information, medical or supply enquiries, please contact: drug.safety@wockhardt.co.uk
For stock control queries, please contact: customer.services@wockhardt.co.uk
Full drug alert can be viewed here.
Posted in: Dispensing & Supply
